| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NRNEPH.2014.38 |
| P698 | PubMed publication ID | 24642799 |
| P50 | author | Munther A. Khamashta | Q73418907 |
| P2093 | author name string | Dario Roccatello | |
| Maria José Cuadrado | |||
| Savino Sciascia | |||
| P2860 | cites work | A Systematic Review and Meta-Analysis of Pregnancy Outcomes in Patients with Systemic Lupus Erythematosus and Lupus Nephritis | Q22305768 |
| Thrombosis, abortion, cerebral disease, and the lupus anticoagulant | Q24675412 | ||
| IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis | Q28191996 | ||
| Increased incidence of antiphospholipid antibodies in left ventricular assist system recipients | Q78043773 | ||
| Antiphospholipid antibodies are a risk factor for early renal allograft failure | Q78106843 | ||
| [Primary antiphospholipid syndrome associated with malignant hypertension] | Q80245216 | ||
| Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome | Q80249563 | ||
| Antiphospholipid antibodies and hypertension | Q80994387 | ||
| The relationship between anticardiolipin antibodies and vascular access occlusion in patients on hemodialysis | Q81664877 | ||
| Clinical significance of antiphospholipid antibodies on allograft and patient outcome after kidney transplantation | Q82137974 | ||
| IgM anti-β2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus | Q82694997 | ||
| Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies | Q83389363 | ||
| [Renal infarction in systemic lupus with antiphospholipid syndrome: role of hydroxychloroquine withdrawal? Comment on the article by Szymezak et al] | Q83432498 | ||
| Eculizumab and renal transplantation in a patient with catastrophic antiphospholipid syndrome: effect of heparin on complement activation | Q83447343 | ||
| Ten-yr renal allograft survival of patients with antiphospholipid antibody syndrome | Q83902624 | ||
| Primary prevention in antiphospholipid antibody carriers | Q84227534 | ||
| Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome | Q84302617 | ||
| Antiphospholipid antibodies and renal outcomes in patients with lupus nephritis | Q84827345 | ||
| Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies | Q85114877 | ||
| A new dawn of anticoagulation for patients with antiphospholipid syndrome? | Q87384439 | ||
| Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities | Q95422702 | ||
| Nephrological and obstetric complications of the antiphospholipid syndrome | Q28193094 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis | Q33358476 | ||
| Primary antiphospholipid syndrome presenting as renal vein thrombosis and membranous nephropathy | Q33394629 | ||
| Thrombotic microangiopathy and associated renal disorders | Q33402372 | ||
| A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome | Q33404206 | ||
| Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post-renal biopsy in antiphospholipid antibody-positive patients | Q33410947 | ||
| Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants | Q33458492 | ||
| Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome | Q33562467 | ||
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
| Epidemiology of the antiphospholipid antibody syndrome | Q33916234 | ||
| Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients | Q33944778 | ||
| Morphology of vascular, renal, and heart lesions in the antiphospholipid syndrome: relationship to pathogenesis | Q34108988 | ||
| The pathogenesis of the antiphospholipid syndrome | Q34332601 | ||
| 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends | Q34400373 | ||
| Pathogenic mechanisms mediating antiphospholipid syndrome | Q34404108 | ||
| The expanding spectrum of renal diseases associated with antiphospholipid syndrome | Q35140898 | ||
| Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension | Q35552039 | ||
| Antiphospholipid syndrome and the kidneys | Q36502421 | ||
| Kidney disease in antiphospholipid syndrome | Q36552689 | ||
| Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry | Q36670025 | ||
| Bilateral renal infarction in a lupus patient: an unusual pathology | Q36881159 | ||
| Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus | Q37158591 | ||
| Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy. | Q37339048 | ||
| Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review | Q37356697 | ||
| New approaches for managing antiphospholipid syndrome | Q37404485 | ||
| What nephrologists need to know about antiphospholipid syndrome | Q37768573 | ||
| Management of refractory anti-phospholipid syndrome | Q37874003 | ||
| The clinical relevance of IgA anticardiolipin and IgA anti-β2 glycoprotein I antiphospholipid antibodies: a systematic review | Q38040947 | ||
| Catastrophic antiphospholipid syndrome (CAPS). | Q38049765 | ||
| Use of new oral anticoagulants in antiphospholipid syndrome | Q38104683 | ||
| Renal transplantation in lupus nephritis: a Brazilian cohort | Q38406781 | ||
| Hypertension, renal artery stenosis and the "primary" antiphospholipid syndrome | Q39245962 | ||
| A reversible bilateral renal artery stenosis in association with antiphospholipid syndrome | Q73540179 | ||
| Lack of association between antiphospholipid antibody and WHO classification in lupus nephritis | Q73611473 | ||
| Endstage renal failure in primary antiphospholipid syndrome--case report and review of literature | Q73817841 | ||
| The renal pathology of primary antiphospholipid syndrome: a distinctive form of endothelial injury | Q73939186 | ||
| Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone | Q74395392 | ||
| The intrarenal vascular lesions associated with primary antiphospholipid syndrome | Q74597824 | ||
| Antiphospholipid antibodies are a risk factor for early renal allograft failure: isolation of antiphospholipid antibodies from a thrombosed renal allograft | Q74616049 | ||
| Antibodies to endothelial cells in borderline hypertension | Q77296591 | ||
| [Anticardiolipin antibodies in hemodialysis patients and in renal transplant recipients: prevalence and significance] | Q77490711 | ||
| Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients | Q77916198 | ||
| Noninvasive investigation for renal artery stenosis: contrast-enhanced magnetic resonance angiography and color Doppler sonography as compared to digital subtraction angiography | Q39585911 | ||
| Imaging modalities for renal artery stenosis in suspected renovascular hypertension: prospective intraindividual comparison of color Doppler US, CT angiography, GD-enhanced MR angiography, and digital substraction angiography | Q39796993 | ||
| Frequent hemodialysis graft thrombosis: association with antiphospholipid antibodies | Q40738058 | ||
| Renal infarction and thrombosis of the infrarenal aorta in a 35-year-old man with primary antiphospholipid syndrome. | Q40986119 | ||
| Repeated renal infarction in native and transplanted kidneys due to left ventricular thrombus formation caused by antiphospholipid antibody syndrome | Q41130615 | ||
| Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus | Q41705531 | ||
| Prevention of thrombosis relapse in antiphospholipid syndrome patients refractory to conventional therapy using intravenous immunoglobulin. | Q41929738 | ||
| Are antiphospholipid antibodies clinically relevant in dialysis patients? | Q42063764 | ||
| The challenge of pregnancy for patients with SLE. | Q43490656 | ||
| IgA antibodies against β2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality | Q43672062 | ||
| Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. | Q43829967 | ||
| Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease | Q44114961 | ||
| Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry". | Q44550364 | ||
| Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy | Q44641118 | ||
| GAPSS: the Global Anti-Phospholipid Syndrome Score | Q44993606 | ||
| Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. | Q45034886 | ||
| Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation | Q45168730 | ||
| Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS. | Q45215095 | ||
| CAPS Registry | Q45230040 | ||
| Bilateral renal artery occlusion in a patient with primary antiphospholipid antibody syndrome: thrombosis, vasculitis or both? | Q45238605 | ||
| End-stage renal disease from glomerulonephritis associated with anti-phospholipid syndrome. | Q45961802 | ||
| Catastrophic antiphospholipid syndrome - 20 years later | Q46147103 | ||
| Management of end-stage renal disease patients with antiphospholipid antibody syndrome | Q46452620 | ||
| Antiphospholipid antibodies and renal transplantation: a risk assessment | Q47383313 | ||
| Incidence of arteriovenous thrombosis and the role of anticardiolipin antibodies in hemodialysis patients | Q47796229 | ||
| Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. | Q50619255 | ||
| Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. | Q51158264 | ||
| Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. | Q52866849 | ||
| Post-partum bilateral renal cortical necrosis in antiphospholipid syndrome and systemic lupus erythematosus. | Q53110783 | ||
| Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. | Q53159273 | ||
| Anticardiolipin antibodies in hemodialysis patients with hepatitis C and their role in fistula failure. | Q53853158 | ||
| Antiphospholipid syndrome | Q55891386 | ||
| Malignant hypertension in antiphospholipid syndrome without overt lupus nephritis | Q58622256 | ||
| Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure | Q67259233 | ||
| Renal involvement in primary antiphospholipid syndrome | Q67908661 | ||
| Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus | Q68026186 | ||
| [Antiphospholipid antibodies in systemic lupus erythematosus: incidence, significance and relation to lupus nephritis] | Q69217363 | ||
| Reversible renal failure in the primary antiphospholipid syndrome--a report of two cases | Q70482551 | ||
| Malignant hypertension and antiphospholipid syndrome | Q71443990 | ||
| Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis | Q71984959 | ||
| Vasculitis in the antiphospholipid syndrome: culprit or consort? | Q72002940 | ||
| The management of thrombosis in the antiphospholipid-antibody syndrome | Q72619159 | ||
| Hypertension and the antiphospholipid antibodies | Q72692336 | ||
| Prevalence of lupus anticoagulant and anticardiolipin antibodies in haemodialysis patients | Q72728140 | ||
| beta 2-Glycoprotein I-dependent and-independent anticardiolipin antibody in patients with end-stage renal disease | Q72762661 | ||
| Anticardiolipin antibodies in patients on regular hemodialysis: an epiphenomenon? | Q72914931 | ||
| Association of anticardiolipin antibodies with vascular access occlusion in hemodialysis patients: cause or effect? | Q73314967 | ||
| Primary antiphospholipid syndrome: functional outcome after 10 years | Q73324341 | ||
| P433 | issue | 5 | |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| P304 | page(s) | 279-289 | |
| P577 | publication date | 2014-03-18 | |
| P1433 | published in | Nature Reviews Nephrology | Q2079275 |
| P1476 | title | Renal involvement in antiphospholipid syndrome | |
| P478 | volume | 10 |
| Q64074557 | Acute renal infarction, transient ischemic attack, and biventricular thrombi secondary to substance use disorder: A case report |
| Q59075500 | An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions |
| Q64042038 | Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study |
| Q90312460 | Antiphospholipid Syndrome and Kidney Involvement: New Insights |
| Q91390119 | Antiphospholipid syndrome - an update |
| Q37228076 | Association between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort study |
| Q92740148 | Atypical hemolytic uremic syndrome: a syndrome in need of clarity |
| Q56806670 | Autoantibodies in SLE: Specificities, Isotypes and Receptors |
| Q33991334 | Clinicopathological correlations in lupus nephritis; a single center experience |
| Q33423959 | Current treatment of antiphospholipid syndrome: lights and shadows |
| Q47998109 | Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances |
| Q33421814 | Difficult clinical situations in the antiphospholipid syndrome |
| Q62588865 | Effect of Thrombophilic Factors on Renal Graft Function: A Single-Center Experience |
| Q38930294 | Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence |
| Q55213947 | Lupus Nephritis with Coexistent Antiphospholipid Antibodies Associated Nephropathy: A Case Report and Literature Review. |
| Q95592748 | Lupus nephritis |
| Q36275483 | Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system |
| Q33815975 | Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes. |
| Q34436283 | Plasmapheresis in a patient with antiphospholipid syndrome before living-donor kidney transplantation: a case report |
| Q35521471 | Primary antiphospholipid syndrome presenting as antiphospholipid syndrome nephropathy: a case report |
| Q54967401 | Renal Involvement in Antiphospholipid Syndrome. |
| Q38838855 | Renal involvement in primary antiphospholipid syndrome |
| Q38873953 | The antiphospholipid syndrome: from pathophysiology to treatment. |
| Q38931719 | The clinical and pathological characteristics of nephropathies in connective tissue diseases in the Japan Renal Biopsy Registry (J-RBR). |
| Q33904653 | The role of neutrophils and NETosis in autoimmune and renal diseases |
| Q64388937 | Two-Parametric Immunological Score Development for Assessing Renal Involvement and Disease Activity in Systemic Lupus Erythematosus |
Search more.